Approval · Notice of Compliance 9282 · 2008
PRIVIGEN: Notice of Compliance 9282
Issued January 9, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9282
- Date
- January 9, 2008
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRIVIGEN | 02304619 | Marketed |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 10 PER